Article MedTech Strategist, March 27 2018
February 5, 2019. REGENSBURG, Germany, and ROCHESTER, Minn. — numares and Mayo Clinic Laboratories have announced a collaboration to develop clinical diagnostic tests that will measure clusters of risk factors as opposed to individual biomarkers. The unique testing will use nuclear magnetic resonance (NMR) technology, focusing on cardiovascular disease, kidney disease, and liver cancer — among a few other specific diseases.
Regensburg, October 11 2018. numares along with clinical study partners from three European medical centers will be presenting their results on a novel method for the accurate assessment of glomerular filtration rate (GFR) at the ASN Kidney Week, being held October 23-28, 2018 in San Diego, CA. The method, based on nuclear magnetic resonance (NMR) spectroscopy and machine learning tools, allows GFR testing as simple as serum creatinine but as accurate as tracer-based plasma clearance methods. The approach outperforms GFR estimation method by standard creatinine or cystatin-c and provides additional pathophysiological insights.
PARASOL multicenter study to continue building clinical case for non-invasive renal allograft rejection testing with AXINON®renalTX-SCORE®UMBRELLA results to be presented at upcoming transplant conferences: ATC and TTS 2018
Please find here numares' old press releases.
Tel.: +49 941 2809 49-14